Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20230526005057/en/FORE-Biotherapeutics-to-Present-Promising-New-Data-from-Phase-12a-Trial-Evaluating-Plixorafenib-FORE8394-in-Patients-With-BRAF-Altered-Advanced-Solid-and-Central-Nervous-System-Tumors-at-ASCO-2023